BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7662887)

  • 1. Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS; Altomare C; Cellamare S; Carotti A; Thull U; Carrupt PA; Testa B; Jenner P; Marsden CD
    Neuroreport; 1995 May; 6(8):1105-8. PubMed ID: 7662887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 Nov; 50(11):1903-11. PubMed ID: 8615871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration.
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1996 Jun; 51(11):1503-11. PubMed ID: 8630091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Neurodegeneration; 1996 Sep; 5(3):265-74. PubMed ID: 8910905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Neurosci Lett; 1996 Mar; 206(1):37-40. PubMed ID: 8848276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1996 Jul; 52(1):29-34. PubMed ID: 8678905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.
    McNaught KS; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1998 Oct; 56(8):921-33. PubMed ID: 9776302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease.
    Han J; Cheng FC; Yang Z; Dryhurst G
    J Neurochem; 1999 Oct; 73(4):1683-95. PubMed ID: 10501216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain.
    Suzuki K; Mizuno Y; Yamauchi Y; Nagatsu T; Mitsuo Y
    J Neurol Sci; 1992 Jun; 109(2):219-23. PubMed ID: 1353109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-like compounds on mitochondrial respiration.
    Suzuki K; Mizuno Y; Yoshida M
    Adv Neurol; 1990; 53():215-8. PubMed ID: 2122645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease.
    Yoshino H; Nakagawa-Hattori Y; Kondo T; Mizuno Y
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):27-34. PubMed ID: 1347219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors.
    Seaton TA; Cooper JM; Schapira AH
    Brain Res; 1997 Nov; 777(1-2):110-8. PubMed ID: 9449419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.
    Storch A; Ott S; Hwang YI; Ortmann R; Hein A; Frenzel S; Matsubara K; Ohta S; Wolf HU; Schwarz J
    Biochem Pharmacol; 2002 Mar; 63(5):909-20. PubMed ID: 11911843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y; Sone N; Saitoh T
    J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endogenous amine 1-methyl-1,2,3,4- tetrahydroisoquinoline prevents the inhibition of complex I of the respiratory chain produced by MPP(+).
    Parrado J; Absi E; Ayala A; CastaƱo A; Cano J; Machado A
    J Neurochem; 2000 Jul; 75(1):65-71. PubMed ID: 10854248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease.
    Shen XM; Li H; Dryhurst G
    J Neural Transm (Vienna); 2000; 107(8-9):959-78. PubMed ID: 11041275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
    Storch A; Kaftan A; Burkhardt K; Schwarz J
    Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion.
    Mizuno Y; Saitoh T; Sone N
    Biochem Biophys Res Commun; 1987 Mar; 143(3):971-6. PubMed ID: 3494449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG; Castagnoli N; Rollema H
    Neurosci Lett; 1989 May; 100(1-3):306-12. PubMed ID: 2788253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) serves as methyl donor for dopamine: a possible mechanism of action.
    Charlton CG
    J Geriatr Psychiatry Neurol; 1992; 5(2):114-8. PubMed ID: 1590912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.